A Qsymia CardiovascuLAr morbIdity and Mortality (AQCLAIM) Study in Subjects with Documented Cardiovascular Disease.
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2016
Price : $35 *
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Cardiovascular disorders; Obesity
- Focus Therapeutic Use
- Acronyms AQCLAIM
- Sponsors PPD; VIVUS
- 05 Sep 2014 New source identified and integrated (United Kingdom Clinical Research Network record:15440)
- 22 Oct 2013 Status changed from planning to recruiting, according to European Clinical Trials Database record.
- 22 Oct 2013 New source identified and integrated: European Clinical Trials Database record.